Company profileVideosCompany news

Nanoform (Helsinki, Finland) is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to reduce attrition in clinical trials and enhance their molecules’ formulation performance through its nanoforming™ services. The Company’s patented and scalable Controlled Expansion of Supercritical Solutions (CESS®) technology produces nano-formed active pharmaceutical ingredient particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Nanoform’s unique technology provides novel opportunities in many value-enhancing, drug delivery applications.

 

Website: https://nanoform.com/en/

Email: [email protected]

Telephone: +358 29 370 0150

Address: Cultivator II, Viikinkaari 4, FI-00790 Helsinki, Finland

Watch Christian Jones, Chief Commercial Officer at Nanoform (Helsinki, Finland), discuss some of the challenges that exist in the current drug discovery and development market, how nanoparticles and nanotechnology may impact drug delivery, pharmaceutical efficiency and drug doses, and what Nanoform’s mission in all this is.